Overall, our findings provide new evidence indicating that reduced levels of RBPMS contribute to the cell growth and invasion as well as drug resistance of ovarian cancer cells as well as that RBPMS could act as a tumor suppressor gene in these cells. Here, RBPMS is linked to ovarian carcinoma.